Skip to Content

Case Study

Meet Milestones Despite Delays With 1Source

When a leading biopharmaceutical company needed to meet the planned First Patient In (FPI) date of their Phase I clinical study but experienced a four-week delay in protocol finalization, Spaulding 1Source™ kept them on track. Faced with a tight schedule, Spaulding Clinical:

  • Began study database development using the draft protocol and 1Source’s built-in resources
  • Implemented changes and introduced new elements with a dedicated team
  • Cut review timelines in half

1Source Data Management

Our single-data-source system and extensive biometric services enabled greater collaboration with the sponsor and helped maintain their development program and funding. While 1Source consistently accelerates final protocol to database live with a four-week turnaround, its robust features allowed us to begin development prior to protocol finalization and meet FPI with proactive, high-quality solutions.

Explore how Spaulding Clinical kept delays from impacting trial timelines through the advanced features of Spaulding 1Source

Back to Resources

Ready to partner with Spaulding Clinical for your Phase I study?

Let’s Talk